Literature DB >> 26060908

Genetic Causes of Generalized Epilepsies.

Ingo Helbig1.   

Abstract

Generalized epilepsies, particularly the idiopathic or genetic generalized epilepsies (GGEs), represent some of the most common epilepsies. Clinical genetic data including family studies and twin studies provide compelling evidence for a prominent genetic impact. The first decade of the 21st century was marked by progress in understanding the basic biology of generalized epilepsies including generalized/genetic epilepsies with febrile seizures plus (GEFS+) and GGE through studies of large families, discovering causative mutations in SCN1A, SCN1B, GABRG2, and GABRA1. Subsequently, recurrent microdeletions at 15q13.3, 16p13.11, and 15q11.2 were found to be relevant risk factors for nonfamilial GGE. Genes for epileptic encephalopathies such as SLC2A1 were rediscovered in GGE, highlighting the biological continuum between different epilepsies. Genome-wide studies examining common genetic risk factors identified common variants in SCN1A, indicating a convergence of shared pathophysiological pathways in various types of epilepsies. In the era of next-generation sequencing, however, the GGEs appear more complex than expected, and small or moderately sized studies give only a limited genetic perspective. Thus, there is a strong impetus for large collaborative investigations on an international level. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26060908     DOI: 10.1055/s-0035-1552922

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  14 in total

Review 1.  Genetic Testing in Pediatric Epilepsy.

Authors:  Tristan T Sands; Hyunmi Choi
Journal:  Curr Neurol Neurosci Rep       Date:  2017-05       Impact factor: 5.081

2.  β1-C121W Is Down But Not Out: Epilepsy-Associated Scn1b-C121W Results in a Deleterious Gain-of-Function.

Authors:  Larisa C Kruger; Heather A O'Malley; Jacob M Hull; Amanda Kleeman; Gustavo A Patino; Lori L Isom
Journal:  J Neurosci       Date:  2016-06-08       Impact factor: 6.167

Review 3.  Involvement of cortical fast-spiking parvalbumin-positive basket cells in epilepsy.

Authors:  X Jiang; M Lachance; E Rossignol
Journal:  Prog Brain Res       Date:  2016-06-07       Impact factor: 2.453

Review 4.  Understanding Genotypes and Phenotypes in Epileptic Encephalopathies.

Authors:  Ingo Helbig; Abou Ahmad N Tayoun
Journal:  Mol Syndromol       Date:  2016-08-20

5.  Genetic Landscape of SCN1A Variants in a Turkish Cohort with GEFS+ Spectrum and Dravet Syndrome.

Authors:  Ayberk Türkyılmaz; Emine Tekin; Oğuzhan Yaralı; Alper Han Çebi
Journal:  Mol Syndromol       Date:  2022-02-22

6.  Novel SCN1A and GABRA1 Gene Mutations With Diverse Phenotypic Features and the Question on the Existence of a Broader Spectrum of Dravet Syndrome.

Authors:  Maria P Gontika; Christopher Konialis; Constantine Pangalos; Antigone Papavasiliou
Journal:  Child Neurol Open       Date:  2017-05-08

7.  Temperature-dependent changes in neuronal dynamics in a patient with an SCN1A mutation and hyperthermia induced seizures.

Authors:  C Peters; R E Rosch; E Hughes; P C Ruben
Journal:  Sci Rep       Date:  2016-09-01       Impact factor: 4.379

8.  Perception and Attitude of the General Population towards Epilepsy in Jeddah, Saudi Arabia.

Authors:  Hussein Algahtani; Bader Shirah; Alhussain Alzahrani; Mostafa Shaheen
Journal:  J Epilepsy Res       Date:  2019-06-30

9.  Mapping the knowledge structure and trends of epilepsy genetics over the past decade: A co-word analysis based on medical subject headings terms.

Authors:  Jing Gan; Qianyun Cai; Peter Galer; Dan Ma; Xiaolu Chen; Jichong Huang; Shan Bao; Rong Luo
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 10.  Cognitive Function in Genetic Generalized Epilepsies: Insights From Neuropsychology and Neuroimaging.

Authors:  Corey Ratcliffe; Britta Wandschneider; Sallie Baxendale; Pamela Thompson; Matthias J Koepp; Lorenzo Caciagli
Journal:  Front Neurol       Date:  2020-03-10       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.